Increased incidence of IgA antibodies to the epstein-barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia
Authors:
- 15 July 1986
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 38 (1) , 55-59
Abstract
Antibody titers to Epstein-Barr virus (EBV)-associated early antigens (EA) and the viral capsid antigen (VCA) were determined by ELISA on 263 sera obtained from healthy donors, patients with Hodgkin's disease (HD), non-Hodgkin lymphomas (NHL), infectious mononucleosis (IM), Burkitt's lymphoma (BL), and nasopharyngeal carcinoma (NPC). As expected, most lymphoma patients showed markedly elevated anti-VCA IgG and anti-EA IgG antibody titers. Only one patient in the NHL group (n = 56) consisting of patients with lymphomas other than chronic lymphocytic leukemia (CLL) and hairy-cell leukemia (HCL), and 3 patients with HCL (n = 19) had high antibody titers of the IgA class to VCA and EA. Seventeen out of 48 patients (36%) with CLL had high IgA anti-VCA titers and 10 of these sera (21%) also contained IgA anti-EA. The geometric mean titer (GMT) of IgA anti-VCA was 2,510, the GMT of IgA anti-EA was 780. These antibody titers were about 10 times lower than the corresponding GMT of the NPC patients investigated in this study. The elevated IgG and IgA antibody titers to VCA and EA in CLL and HCL patients seem to reflect an immunodeficiency secondary to the malignant disease leading to reactivation of latent EBV infection. The possibility that at least some of these B-cell lymphomas are associated with EBV cannot be excluded.Keywords
This publication has 27 references indexed in Scilit:
- Purification of a polypeptide complex (p52) belonging to the D-subspecificites of Epstein-Barr virus-induced early antigensVirology, 1986
- Principles and present status of a prospective multicenter study on the clinical relevance of the kiel classificationAnnals of Hematology, 1981
- Epstein-Barr Virus Infection in Renal Transplant RecipientsAnnals of Internal Medicine, 1980
- Epstein‐barr virus specific IgA serum antibodies in nasopharyngeal and other respiratory carcinomasInternational Journal of Cancer, 1979
- The Virus as the Etiologic Agent of Infectious Mononucleosis1979
- DEMONSTRATION OF CELL SURFACE ANTIGENS AND THEIR ANTIBODIES BY THE PEROXIDASE-ANTIPEROXIDASE METHODTransplantation, 1978
- Oropharyngeal Excretion of Epstein-Barr Virus by Patients with Lymphoproliferative Disorders and by Recipients of Renal HomograftsAnnals of Internal Medicine, 1978
- Antibodies to Epstein-Barr Virus-Associated Nuclear Antigen in Infectious MononucleosisThe Journal of Infectious Diseases, 1974
- Prevalence of Oropharyngeal Excreters of Leukocyte-Transforming Agents among a Human PopulationNew England Journal of Medicine, 1973
- Epstein‐barr virus (EBV)‐associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphomaInternational Journal of Cancer, 1971